A fresh study, covering “Liver Cancer Diagnostics Market Forecast, Trend Analysis & Competition Tracking – Global Review 2017 to 2022” has been broadcasted to wide online repository of Fact MR, which presents deep focus on the healthcare market. This smart study contains precise data that offers a clear insight about market current scenario and future projections for the benefit of readers. Moreover, the study enclosed significant data which tends to make the research a powerful source for analysts and industry experts who are looking to gain necessary knowledge about the prevailing market trends, opportunities and drivers present in the liver cancer diagnostics market.
Request for Sample Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=73
Takeaways from the Global Liver Cancer Diagnostics Market
1- In terms of revenues, North America will remain the most lucrative region in the global market for liver cancer diagnostics. In addition, liver cancer diagnostics markets in North America and Europe will exhibit expansion at similar CAGRs through 2022.
2- Liver cancer diagnostics markets in Japan and MEA will exhibit a sluggish growth during the forecast period.
3- Biopsy tests will continue to exhibit the highest CAGR through 2022, among test type in the global market, followed by LFTs.
4- AFP test is projected to remain sought-after for liver cancer diagnostics over the forecast period. Revenues from AFP tests are estimated to hold more than half market share in 2017, and are expected to attain 52 BPS in their market share by 2022-end.
5- Hospital-associated labs are expected to remain sought-after in the market for liver cancer diagnostics. Liver cancer diagnostics in the hospital-associated labs are expected to account for largest revenues during the forecast period.
6- Independent diagnostic laboratories will continue to be the second most lucrative segment among end-users in the global market for liver cancer diagnostics.
7- Diagnosis of liver cancer in cancer research institutes will continue to register the highest CAGR over the forecast period.
The report has also profiled companies that will remain active in expansion of global liver cancer diagnostics market through 2022. These include Illumina, Inc.
Sysmex Corporation, Danaher Corporation, Biocept, Inc., and Foundation Medicine, Inc.
Browse Full Report with TOC – https://www.factmr.com/report/73/liver-cancer-diagnostics-market
Table of Contents:
- Global Liver Cancer Diagnostics Market – Executive Summary
- Global Liver Cancer Diagnostics Market Overview
2.1.1. Global Liver Cancer Diagnostics Market Taxonomy
2.1.2. Global Liver Cancer Diagnostics Market Definition
2.2. Global Liver Cancer Diagnostics Market Size (US$ Mn) and Forecast, 2012-2022
2.2.1. Global Liver Cancer Diagnostics Market Y-o-Y Growth
2.3. Global Liver Cancer Diagnostics Market Dynamics
2.4. Supply Chain
2.6. List of Distributors
2.7. Average Pricing Analysis
2.9. Key Participants Market Presence (Intensity Map) By Region
- Global Liver Cancer Diagnostics Market Analysis and Forecast By Test Type
3.1. Global Liver Cancer Diagnostics Market Size and Forecast By Test Type, 2012-2022
3.1.1. AFP Tests Liver Cancer Diagnostics Market Size and Forecast, 2012-2022
188.8.131.52. Revenue (US$ Mn) Comparison, By Region
184.108.40.206. Market Share Comparison, By Region
220.127.116.11. Y-o-Y growth Comparison, By Region
Check Discount on this Report – https://www.factmr.com/connectus/sample?flag=D&rep_id=73
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.